Page last updated: 2024-10-22

altretamine and Epilepsy

altretamine has been researched along with Epilepsy in 1 studies

Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.

Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Research Excerpts

ExcerptRelevanceReference
"Phenytoin levels were reduced to 37% of the original values, although the drug was given intravenously."1.27An interaction between cytostatic and anticonvulsant drugs. ( de Voogd-van der Straaten, I; Neef, C, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neef, C1
de Voogd-van der Straaten, I1

Other Studies

1 other study available for altretamine and Epilepsy

ArticleYear
An interaction between cytostatic and anticonvulsant drugs.
    Clinical pharmacology and therapeutics, 1988, Volume: 43, Issue:4

    Topics: Adenocarcinoma, Papillary; Adult; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carba

1988